Variant report
Variant | esv3324872 |
---|---|
Chromosome Location | chr2:36954923-36956971 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:36956863..36959854-chr2:36963372..36965753,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533270456 | chr2:36954972-36954973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4670166 | chr2:36955005-36955006 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs367971257 | chr2:36955031-36955032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569959487 | chr2:36955045-36955046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372130963 | chr2:36955052-36955053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551746180 | chr2:36955060-36955061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566912153 | chr2:36955070-36955071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114240168 | chr2:36955071-36955072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs78597396 | chr2:36955090-36955091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567944746 | chr2:36955106-36955107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546868584 | chr2:36955121-36955122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187375240 | chr2:36955139-36955140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553627334 | chr2:36955140-36955141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4670167 | chr2:36955175-36955176 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs573979417 | chr2:36955215-36955216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557790459 | chr2:36955217-36955218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192099903 | chr2:36955289-36955290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535606025 | chr2:36955304-36955305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs114885757 | chr2:36955311-36955312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372889622 | chr2:36955312-36955313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376079285 | chr2:36955378-36955379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114373579 | chr2:36955414-36955415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575276847 | chr2:36955447-36955448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs148280654 | chr2:36955474-36955475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370434748 | chr2:36955575-36955576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559136272 | chr2:36955576-36955577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550673345 | chr2:36955601-36955602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116572185 | chr2:36955614-36955615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551587409 | chr2:36955685-36955686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563800073 | chr2:36955687-36955688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530844191 | chr2:36955727-36955728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557729190 | chr2:36955865-36955866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs11896498 | chr2:36955943-36955944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201033795 | chr2:36955965-36955966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201789401 | chr2:36955973-36955974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11885812 | chr2:36955980-36955981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115132039 | chr2:36956014-36956015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567637234 | chr2:36956058-36956059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184093360 | chr2:36956061-36956062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs538041100 | chr2:36956082-36956083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562018653 | chr2:36956103-36956104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs374085616 | chr2:36956118-36956119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369954346 | chr2:36956135-36956136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78157991 | chr2:36956144-36956145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574026433 | chr2:36956172-36956173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547275533 | chr2:36956174-36956175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571875803 | chr2:36956292-36956293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539222857 | chr2:36956328-36956329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557611029 | chr2:36956359-36956360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs11124535 | chr2:36956372-36956373 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22737080 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:36941000-36960200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr2:36942600-36968800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr2:36948400-36958800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr2:36951600-36957200 | Weak transcription | Ovary | ovary |
5 | chr2:36951800-36958800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr2:36952000-36956800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr2:36956200-36957000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr2:36956200-36957000 | Enhancers | NHDF-Ad | bronchial |
9 | chr2:36956800-36958000 | Strong transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |